Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,802 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06753045Recruiting
Heart health study with wearable device and smartphone app
This study uses a wearable wrist device to monitor your health data and look for early signs of heart problems. It's for people with or without heart disease, and involves wearing a watch-like device and using a smartphone app.
New Orleans, LouisianaAges 18–120 - NCT06753565RecruitingPhase 2
L-carnitine supplement for rheumatoid arthritis
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
Cairo, DemerdashAges 18–60 - NCT06753682Recruiting
Healthy plant-based diet and gum disease treatment for Chinese adults
This study tests whether eating more fresh vegetables and fruits can improve treatment outcomes for gum disease. You may qualify if you have gum disease, are Chinese, and currently eat fewer than the recommended daily servings of vegetables and fruits.
Hong KongAges 18–64 - NCT06754371RecruitingPhase 4
Tranexamic acid to prevent heavy bleeding after C-section in autoimmune disease
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT06755008Recruiting
Cell repair for lung health in COPD
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
Montpellier, HéraultAges 18 years+ - NCT06755151RecruitingPhase 3
Fenofibrate for primary biliary cholangitis: a real-world study
This study tests fenofibrate, a medicine that may help lower liver enzymes in people with primary biliary cholangitis (PBC). It looks at how well the drug works in everyday medical practice.
Xi'an, ShaanxiAges 18–75 - NCT06755541RecruitingPhase 3
Fenofibrate plus ursodeoxycholic acid for PBC: a real-world study
This trial is testing whether adding fenofibrate to the standard PBC medicine ursodeoxycholic acid helps people with primary biliary cholangitis. It's a real-world study, meaning it looks at how treatments work in everyday practice. You can join only if you have already completed an earlier fenofibrate study.
Xi'an, ShaanxiAges 18–75 - NCT06756152RecruitingPhase 2/Phase 3
Preventing GVHD after transplant for blood cancers in children and young adults
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
MoscowAges 1 day–21 years - NCT06756789Recruiting
Comparing standard vs. tailored limb lengths in gastric bypass
This study compares two different ways of measuring the length of the small intestine during a type of weight loss surgery called gastric bypass. If you are eligible, you may help determine which approach leads to better weight loss results.
Coimbatore, Tamil NaduAges 18–65 - NCT06757049Recruiting
Using the Edwards MITRIS RESILIA valve in Asian patients
This study looks at how well a new mitral valve (the Edwards MITRIS RESILIA) works in people of Asian descent. It aims to see if this valve is safe and effective for patients who need mitral valve replacement.
Seoul, SONGPA-GUAges 19 years+ - NCT06758505Recruiting
Stroke recovery study: social activities after stroke
This study tests a rehabilitation program to help people who have had a stroke get back to the social activities they enjoyed before. If you have trouble joining in activities with family or friends, this program may help you reconnect.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06758609Recruiting
Brain cooling plus clot removal for large artery stroke
This trial tests a new treatment that combines cooling the brain with a catheter and removing the clot to restore blood flow — for people who have had a major stroke in the front part of the brain within the last 24 hours.
Guangzhou, GuangdongAges 18–85 - NCT06758700RecruitingPhase 2
Teniposide for advanced small cell lung cancer with c-Myc
This trial tests a chemotherapy drug called teniposide for people with a specific type of advanced small cell lung cancer that has gotten worse after prior treatment. The goal is to see if teniposide helps shrink tumors or slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06758817Recruiting
Nutrition, gut health, and rheumatoid arthritis study
This trial tests if a specific diet can improve your rheumatoid arthritis symptoms by affecting your gut bacteria. You may be eligible if you have active RA and are willing to follow a special meal plan for several weeks.
Lisbon, PortugalAges 18 years+ - NCT06760845Recruiting
Using light to diagnose kidney disease
This trial uses a special light technique (Raman spectroscopy) to help diagnose different types of kidney disease. It may provide a faster, less invasive way to understand your condition.
Jinan, ShandongAges Any age - NCT06760923Recruiting
Urine test for ovarian cancer detection and tracking
This study looks at proteins in urine to help find ovarian cancer earlier and track how the disease changes. It aims to provide a non-invasive way to tell the difference between benign and malignant pelvic masses.
Changsha, HunanAges 18 years+ - NCT06763458Recruiting
Balloon angioplasty for minor unstable stroke with brain artery narrowing
This trial tests if balloon angioplasty (opening a narrowed artery with a tiny balloon) can help people who have had a minor stroke and are still having symptoms despite taking blood thinners.
ShenyangAges 18 years+ - NCT06764134Recruiting
Testing a new stapler to prevent pancreatic leaks after surgery
This trial tests a new type of stapler (AEON) used during surgery to remove the left part of the pancreas. The goal is to see if it helps reduce the risk of a leak from the pancreas after surgery.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06764719Recruiting
Hair follicles for cell therapy
This trial tests if special hair follicles can be used for cell replacement therapy in disease. It may help people with certain medical conditions.
Toronto, QuebecAges 18–80 - NCT06764706Recruiting
Risankizumab for moderate-to-severe ulcerative colitis
This study observes how well risankizumab works for people with moderate to severe ulcerative colitis who are already starting it as part of their regular care. It helps doctors learn more about the drug's real-world effects.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06765850Recruiting
Melanoma blood marker study
This study looks at small molecules in your blood (called the metabolome) using special tests. Researchers want to see if these molecules change depending on how your melanoma progresses, which may help improve future care.
Dresden, SaxonyAges 18 years+ - NCT06766253Recruiting
Comparing three breathing tube devices for head-down laparoscopic surgery
This study is comparing three different breathing tube devices (GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask) for people having laparoscopic surgery while tilted head-down. The goal is to see which device works best and most safely.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06767254Recruiting
Using AI to predict early return of multiple myeloma
This study uses artificial intelligence to analyze how multiple myeloma may lead to early relapse. It may help doctors better predict and manage the disease.
Meldola, Forlì-CesenaAges 18 years+ - NCT06767345RecruitingPhase 4
Comparing two cholesterol medicines for plaque stabilization
This study compares two ways to lower cholesterol and stabilize artery plaque in people with coronary artery disease who are having a stent procedure. It tests whether a moderate statin plus ezetimibe works as well as a high-intensity statin alone for stabilizing plaque.
Seoul, SeoulAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,802 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.